Precigen Inc (PGEN)

Dec 21, 2024

Fmr LLC Has $327,000 Stake in Precigen, Inc. (NASDAQ:PGEN) - Defense World

Dec 21, 2024

Dec 20, 2024

Analysts Update Their Estimates For Precigen Inc - Stocks Register

Dec 20, 2024

Dec 17, 2024

Metastatic Triple Negative Breast Cancer Market Expected to Experience Major Growth by 2034, According to DelveInsight | AstraZeneca, BioEclipse Therapeutics, Precigen, Inc, Clovis Oncology, Inc - Barchart

Dec 17, 2024

Dec 17, 2024

Further weakness as Precigen (NASDAQ:PGEN) drops 16% this week, taking five-year losses to 89% - Simply Wall St

Dec 17, 2024

Dec 15, 2024

Precigen's SWOT analysis: biotech firm's stock rides on PRGN-2012 hopes - Investing.com

Dec 15, 2024

Dec 13, 2024

PGEN Stock Touches 52-Week Low at $0.71 Amid Market Challenges - Investing.com Canada

Dec 13, 2024

Dec 11, 2024

Precigen to Participate in the 2024 Cantor Global Healthcare Conference - The Eastern Progress Online

Dec 11, 2024

Dec 08, 2024

Precigen to Participate in the Stifel 2024 Healthcare Conference - The Eastern Progress Online

Dec 08, 2024

Dec 05, 2024

PGEN Stock Plummets to 52-Week Low at $0.77 Amid Market Challenges - Investing.com Nigeria

Dec 05, 2024

Dec 05, 2024

PGEN Stock Plummets to 52-Week Low at $0.77 Amid Market Challenges By Investing.com - Investing.com South Africa

Dec 05, 2024

Dec 01, 2024

Precigen (STU:I5X) Shares Outstanding (EOP) : 292.87 Mil (As of Sep. 2024) - GuruFocus.com

Dec 01, 2024

Dec 01, 2024

Precigen, Inc. (NASDAQ:PGEN) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat

Dec 01, 2024

Nov 29, 2024

Bioinformatics Market to Grow by USD 13.2 Billion (2024-2028), Lower Genetic Sequencing Costs Drive Revenue, Report Highlights AI's Role in TransformationTechnavio - The Malaysian Reserve

Nov 29, 2024

Nov 25, 2024

Precigen's SWOT analysis: biotech stock focuses on RRP treatment - Investing.com

Nov 25, 2024

Nov 25, 2024

Precigen's SWOT analysis: biotech stock focuses on RRP treatment By Investing.com - Investing.com Australia

Nov 25, 2024

Nov 24, 2024

Precigen Reports Q3 2024 Financial Results - MSN

Nov 24, 2024

Nov 20, 2024

Insiders Sold Precigen Prematurely At US$1.41 With Stock Trading Higher - Simply Wall St

Nov 20, 2024

Nov 20, 2024

Precigen (NASDAQ:PGEN shareholders incur further losses as stock declines 13% this week, taking five-year losses to 86% - Yahoo Finance

Nov 20, 2024

Nov 20, 2024

Precigen, Inc. (PGEN) Reports Q3 Loss, Lags Revenue Estimates - MSN

Nov 20, 2024

Nov 19, 2024

Precigen (NASDAQ:PGEN) Given Buy Rating at HC Wainwright - Defense World

Nov 19, 2024

Nov 18, 2024

HC Wainwright Issues Negative Outlook for Precigen Earnings - MarketBeat

Nov 18, 2024

Nov 15, 2024

PGEN stock touches 52-week low at $0.78 amid market challenges - Investing.com Canada

Nov 15, 2024

Nov 15, 2024

HC Wainwright Reiterates Buy Rating for Precigen (NASDAQ:PGEN) - MarketBeat

Nov 15, 2024

Nov 15, 2024

Precigen Inc. (PGEN) Quarterly 10-Q Report - Quartz

Nov 15, 2024

Nov 14, 2024

Precigen Inc (PGEN) Q3 2024 Earnings: EPS Misses at $(0.09), Rev - GuruFocus.com

Nov 14, 2024

Nov 14, 2024

Precigen, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 14, 2024

Nov 14, 2024

Precigen earnings missed, revenue fell short of estimates By Investing.com - Investing.com UK

Nov 14, 2024

Nov 14, 2024

Precigen Reports Third Quarter 2024 Financial Results and Business Updates - Nasdaq

Nov 14, 2024

Nov 14, 2024

Precigen (NASDAQ:PGEN) Shares Cross Below Two Hundred Day Moving AverageTime to Sell? - MarketBeat

Nov 14, 2024

Nov 12, 2024

Precigen CEO to Present at Stifel 2024 Healthcare Conference: Gene Therapy Innovation Spotlight | PGEN Stock News - StockTitan

Nov 12, 2024

Nov 09, 2024

Precigen, Inc. (NASDAQ:PGEN) Receives $7.00 Consensus Price Target from Brokerages - Defense World

Nov 09, 2024

Nov 06, 2024

Precigen, Inc. (NASDAQ:PGEN) Receives $7.00 Consensus Target Price from Analysts - MarketBeat

Nov 06, 2024

Nov 02, 2024

PGEN (Precigen) EBITDA per Share : $-0.52 (TTM As of Jun. 2024) - GuruFocus.com

Nov 02, 2024

Nov 02, 2024

Precigen Announces Pricing of $30.0 Million Public Offering of C - GuruFocus.com

Nov 02, 2024

Oct 31, 2024

Iridian Asset Management LLC CT Grows Stock Position in Precigen, Inc. (NASDAQ:PGEN) - MarketBeat

Oct 31, 2024

Oct 30, 2024

PGEN stock touches 52-week low at $0.82 amid market challenges - Investing.com Australia

Oct 30, 2024

Oct 29, 2024

Precigen to Announce Fourth Quarter and Full Year 2023 Financial Results on March 19th - GuruFocus.com

Oct 29, 2024

Oct 24, 2024

High Growth Tech Stocks To Watch In October 2024 - Simply Wall St

Oct 24, 2024

Oct 18, 2024

Should you Hold Precigen (PGEN)? - Insider Monkey

Oct 18, 2024

Oct 12, 2024

Precigen, Inc. (NASDAQ:PGEN) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat

Oct 12, 2024

Oct 11, 2024

A company insider recently bought 58,823 shares of Precigen Inc [PGEN]. Should You Buy? - Knox Daily

Oct 11, 2024

Oct 11, 2024

Precigen reclaims rights after terminating license agreement By Investing.com - Investing.com Australia

Oct 11, 2024

Oct 11, 2024

Precigen Inc (PGEN) stock analysis: A simple moving average approach - US Post News

Oct 11, 2024

Oct 11, 2024

Precigen reclaims rights after terminating license agreement - Investing.com India

Oct 11, 2024

Oct 11, 2024

Alaunos Therapeutics Ends Licensing Deal, Reassesses Strategy - Yahoo Finance

Oct 11, 2024

Oct 10, 2024

Precigen Terminates License Agreement With Alaunos Therapeutics - MarketWatch

Oct 10, 2024